Senolytic Therapeutics
Chestnut Hill, US · Founded 2017 · Delaware corporation
Founders & leadership
Senolytic Therapeutics was founded in 2017 by Marc Ramis Castelltort.
MR
Marc Ramis CastelltortinCo-Founder2017–2021
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2017
▶$500KraisedAug 2017 · 1 investors · Other Health CareRule 506(b)
▶$500KraisedAug 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc Ramis CastelltortExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $500K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Senolytic Therapeutics?
- Senolytic Therapeutics was founded by Marc Ramis Castelltort in 2017.
- How much funding has Senolytic Therapeutics raised?
- Senolytic Therapeutics has disclosed $500K raised across 1 round.
- Where is Senolytic Therapeutics headquartered?
- Senolytic Therapeutics is headquartered in Chestnut Hill, US.